CEACAM5 and pachyonychia congenita: In a study conducted at Saitama Medical University involving 104 PC patients and 95 control individuals, N-NOSE demonstrated significantly higher sensitivity in detecting early-stage PC compared to the traditional biomarkers CEA and CA19-9 [214].